{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T06:19:37Z","timestamp":1794809977079,"version":"4.9.1"},"reference-count":86,"publisher":"Bentham Science Publishers Ltd.","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction\/Objective:<\/jats:title>\n                    <jats:p>Persistently elevated serum immunoglobulin M (IgM) is commonly\ninterpreted as a marker of acute infection, autoimmune activity, or lymphoproliferation. Sustained\nIgM elevation may represent an underrecognized marker of underlying primary immunodeficiency\ndisorders (PIDs), especially those associated with class-switch recombination defects or immune\ndysregulation. This article aims to highlight the diagnostic value of persistently elevated IgM\nlevels in pediatric PIDs and to propose a practical clinical framework for the evaluation of children\nwith unexplained IgM elevation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We performed a case-based narrative review of the literature on primary immunodeficiencies\nassociated with elevated serum IgM, focusing on pathogenic mechanisms, clinical phenotypes,\nand diagnostic implications. The review was complemented by two pediatric cases from our practice\nin which persistent IgM elevation served as a clue to the diagnosis of distinct primary immunodeficiencies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Persistently increased IgM levels in PIDs may reflect impaired class-switch recombination,\nimpaired germinal center maturation, or chronic immune activation. The two presented cases, ataxiatelangiectasia\nwith a hyper-IgM phenotype and BENTA disease, illustrate how elevated IgM associated\nwith frequent and severe infections, lymphoproliferation, growth impairment, or syndromic\nfeatures may guide clinicians toward immunological and genetic evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Persistent IgM elevation should be interpreted in its clinical context and should not be\ndismissed as a nonspecific laboratory abnormality. A structured diagnostic approach may help distinguish\nsecondary causes, classic hyper-IgM syndromes, and hyper-IgM phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Persistently elevated serum IgM should not be dismissed as a transient abnormality in\nchildren with recurrent infections or immune dysregulation. When interpreted in its clinical context,\nit may serve as a practical indicator for further immunological investigation and diagnosis of PIDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715303480200260716045547","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T07:36:54Z","timestamp":1786088214000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Persistently Elevated Serum IgM: A Diagnostic Red Flag for Primary Immunodeficiencies: A Case-Based Review and Clinical Approach"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6351-5659","authenticated-orcid":true,"given":"Cristina","family":"Tomacinschii","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of\nMoldova | Institute of Mother and Child, Chisinau, Republic of Moldova"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1091-9419","authenticated-orcid":true,"given":"Svetlana","family":"Sciuca","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4116-8156","authenticated-orcid":true,"given":"Mihaela","family":"Bataneant","sequence":"additional","affiliation":[{"name":"Department of Immunology, Second Pediatric Clinic, Clinical Emergency Hospital for Children \u201cLouis Turcanu\u201d, Timisoara, Romania | Third Pediatrics Clinic, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9692-3402","authenticated-orcid":true,"given":"Laszlo","family":"Marodi","sequence":"additional","affiliation":[{"name":"Primary Immunodeficiency Clinical Unit and Laboratory, Department of Dermatology, Venereology and Dermato-Oncology, Semmelweis University, Budapest, Hungary | St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller University, 1230 York Ave, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e20250003","DOI":"10.70962\/jhi.20250003","volume":"1","author":"Poli M.C.","year":"2025","unstructured":"Poli M.C.; Aksentijevich I.; Bousfiha A.A.; Cunningham-Rundles C.; Hambleton S.; Klein C.; Morio T.; Picard C.; Puel A.; Rezaei N.; Sepp\u00e4nen M.R.J.; Somech R.; Su H.C.; Sullivan K.E.; Torgerson T.R.; Meyts I.; Tangye S.G.; Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee. Journal of Human Immunity  2025,1(1),e20250003","journal-title":"Journal of Human Immunity"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s10875-023-01439-1","volume":"43","author":"Sciuca S.","year":"2023","unstructured":"Sciuca S.; Tomacinschii C.; Selevestru R.; Sacara V.; Mar\u00f3di L.; Inborn errors of immunity in the Republic of Moldova: Advances and hope. J Clin Immunol  2023,43(4),714-716","journal-title":"J Clin Immunol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1032358","DOI":"10.3389\/fimmu.2022.1032358","volume":"13","author":"Abolhassani H.","year":"2022","unstructured":"Abolhassani H.; Avcin T.; Bahceciler N.; Balashov D.; Bata Z.; Bataneant M.; Belevtsev M.; Bernatowska E.; Bidl\u00f3 J.; Blazs\u00f3 P.; Boisson B.; Bolkov M.; Bondarenko A.; Boyarchuk O.; Bundschu A.; Casanova J.L.; Chernishova L.; Ciznar P.; Cs\u00fcrke I.; Erd\u0151s M.; Farkas H.; Fomina D.S.; Galal N.; Goda V.; Guner S.N.; Hauser P.; Ilyina N.I.; Iremadze T.; Iritsyan S.; Ismaili-Jaha V.; Jesenak M.; Kelecic J.; Keles S.; Kindle G.; Kondratenko I.V.; Kostyuchenko L.; Kovzel E.; Kriv\u00e1n G.; Kuli-Lito G.; Kum\u00e1novics G.; Kurjane N.; Latysheva E.A.; Latysheva T.V.; L\u00e1z\u00e1r I.; Markelj G.; Markovic M.; Mar\u00f3di L.; Mammadova V.; Medvecz M.; Miltner N.; Mironska K.; Modell F.; Modell V.; Mosd\u00f3si B.; Mukhina A.A.; Murdjeva M.; M\u0171zes G.; Nabieva U.; Nasrullayeva G.; Naumova E.; Nagy K.; Onoz\u00f3 B.; Orozbekova B.; Pac M.; Pagava K.; Pampura A.N.; Pasic S.; Petrosyan M.; Petrovic G.; Pocek L.; Prodeus A.P.; Reisli I.; Ress K.; Rezaei N.; Rodina Y.A.; Rumyantsev A.G.; Sciuca S.; Sediva A.; Serban M.; Sharapova S.; Shcherbina A.; Sitkauskiene B.; Snimshchikova I.; Spahiu-Konjusha S.; Szolnoky M.; Sz\u0171cs G.; Toplak N.; T\u00f3th B.; Tsyvkina G.; Tuzankina I.; Vlasova E.; Volokha A.; Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021. Front Immunol  2022,13,1032358","journal-title":"Front Immunol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.3390\/jcm14186363","volume":"14","author":"Grammatikos A.","year":"2025","unstructured":"Grammatikos A.; Progress in diagnosis and treatment of primary immunodeficiencies. J Clin Med  2025,14(18),6363","journal-title":"J Clin Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.anai.2019.08.012","volume":"123","author":"Marsh R.A.","year":"2019","unstructured":"Marsh R.A.; Orange J.S.; Antibody deficiency testing for primary immunodeficiency: A practical review for the clinician. Ann Allergy Asthma Immunol  2019,123(5),444-453","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"595535","DOI":"10.3389\/fimmu.2020.595535","volume":"11","author":"Jones K.","year":"2020","unstructured":"Jones K.; Savulescu A.F.; Brombacher F.; Hadebe S.; Immunoglobulin M in health and diseases: How far have we come and what next? Front Immunol  2020,11,595535","journal-title":"Front Immunol"},{"key":"ref=7","author":"Sathe A.","year":"2025","unstructured":"Sathe A.; Cusick J.K.; Biochemistry, Immunoglobulin M. StatPearls  2025","journal-title":"StatPearls"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fimmu.2016.00099","volume":"7","author":"Wang H.","year":"2016","unstructured":"Wang H.; Coligan J.E.; Morse H.C.; Emerging functions of natural IgM and its Fc receptor FCMR in immune homeostasis. Front Immunol  2016,7,99","journal-title":"Front Immunol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","volume":"125","author":"Schroeder H.W.","year":"2010","unstructured":"Schroeder H.W.; Cavacini L.; Structure and function of immunoglobulins. J Allergy Clin Immunol  2010,125(2),S41-S52","journal-title":"J Allergy Clin Immunol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.3389\/fimmu.2018.02172","volume":"9","author":"Jhamnani R.D.","year":"2018","unstructured":"Jhamnani R.D.; Nunes-Santos C.J.; Bergerson J.; Rosenzweig S.D.; Class-switch recombination (CSR)\/hyper-IgM (HIGM) syndromes and phosphoinositide 3-kinase (PI3K) defects. Front Immunol  2018,9,2172","journal-title":"Front Immunol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"A404","DOI":"10.1016\/j.autrev.2011.12.001","volume":"11","author":"Duarte-Rey C.","year":"2012","unstructured":"Duarte-Rey C.; Bogdanos D.P.; Leung P.S.C.; Anaya J.M.; Gershwin M.E.; IgM predominance in autoimmune disease: Genetics and gender. Autoimmun Rev  2012,11(6-7),A404-A412","journal-title":"Autoimmun Rev"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clim.2018.11.007","volume":"198","author":"Yazdani R.","year":"2019","unstructured":"Yazdani R.; Fekrvand S.; Shahkarami S.; Azizi G.; Moazzami B.; Abolhassani H.; Aghamohammadi A.; The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management. Clin Immunol  2019,198,19-30","journal-title":"Clin Immunol"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.89624","author":"Chen R.","year":"2020","unstructured":"Chen R.; Primary Immunodeficiency. Rare Diseases  2020","journal-title":"Rare Diseases"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jaip.2016.09.013","volume":"4","author":"de la Morena M.T.","year":"2016","unstructured":"de la Morena M.T.; Clinical phenotypes of hyper-IgM syndromes. J Allergy Clin Immunol Pract  2016,4(6),1023-1036","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3390\/jcm9030818","volume":"9","author":"Gallo V.","year":"2020","unstructured":"Gallo V.; Cirillo E.; Prencipe R.; Lepore A.; Del Vecchio L.; Scalia G.; Martinelli V.; Di Matteo G.; Saunders C.; Durandy A.; Moschese V.; Leonardi A.; Giardino G.; Pignata C.; Clinical, immunological, and functional characterization of six patients with very high IgM levels. J Clin Med  2020,9(3),818","journal-title":"J Clin Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.12688\/f1000research.21553.1","volume":"9","author":"Bucciol G.","year":"2020","unstructured":"Bucciol G.; Meyts I.; Recent advances in primary immunodeficiency: From molecular diagnosis to treatment. F1000 Res  2020,9,194","journal-title":"F1000 Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fimmu.2012.00066","volume":"3","author":"Gr\u00f6nwall C.","year":"2012","unstructured":"Gr\u00f6nwall C.; Vas J.; Silverman G.J.; Protective roles of natural IgM antibodies. Front Immunol  2012,3,66","journal-title":"Front Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0394632015600231","volume":"28","author":"Picchianti Diamanti A.","year":"2015","unstructured":"Picchianti Diamanti A.; Rosado M.M.; Scarsella M.; Ceccarelli S.; Lagan\u00e0 B.; D\u2019Amelio R.; Carsetti R.; Increased serum IgM, immunodeficiency, and autoimmunity: A clinical series. Int J Immunopathol Pharmacol  2015,28(4),547-556","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.0105-2896.2005.00222.x","volume":"203","author":"Durandy A.","year":"2005","unstructured":"Durandy A.; Revy P.; Imai K.; Fischer A.; Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. Immunol Rev  2005,203(1),67-79","journal-title":"Immunol Rev"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0065-2776(06)94009-7","volume":"94","author":"Durandy A.","year":"2007","unstructured":"Durandy A.; Taubenheim N.; Peron S.; Fischer A.; Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies. Advances in Immunology  2007,94,275-306","journal-title":"Advances in Immunology"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.tibs.2020.10.005","volume":"46","author":"Saha T.","year":"2021","unstructured":"Saha T.; Sundaravinayagam D.; Di Virgilio M.; Charting a DNA repair roadmap for immunoglobulin class switch recombination. Trends Biochem Sci  2021,46(3),184-199","journal-title":"Trends Biochem Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.4049\/jimmunol.2300842","volume":"213","author":"Du L.","year":"2024","unstructured":"Du L.; Oksenych V.; Wan H.; Ye X.; Dong J.; Ye A.Y.; Abolhassani H.; Vlachiotis S.; Zhang X.; de la Rosa K.; Hammarstr\u00f6m L.; van der Burg M.; Alt F.W.; Pan-Hammarstr\u00f6m Q.; Orientation regulation of class-switch recombination in human B cells. J Immunol  2024,213(8),1093-1104","journal-title":"J Immunol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41577-019-0214-8","volume":"19","author":"Flemming A.","year":"2019","unstructured":"Flemming A.; Class-switch recombination revised. Nat Rev Immunol  2019,19(10),596-597","journal-title":"Nat Rev Immunol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/imm.13176","volume":"160","author":"Chi X.","year":"2020","unstructured":"Chi X.; Li Y.; Qiu X.; V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: Mechanism and regulation. Immunology  2020,160(3),233-247","journal-title":"Immunology"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e662","DOI":"10.1002\/mco2.662","volume":"5","author":"Liu J.C.","year":"2024","unstructured":"Liu J.C.; Zhang K.; Zhang X.; Guan F.; Zeng H.; Kubo M.; Lee P.; Candotti F.; James L.K.; Camara N.O.S.; Benlagha K.; Lei J.H.; Forsman H.; Yang L.; Xiao W.; Liu Z.; Liu C.H.; Immunoglobulin class-switch recombination: Mechanism, regulation, and related diseases. MedComm  2024,5(8),e662","journal-title":"MedComm"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.clim.2010.01.012","volume":"135","author":"Kracker S.","year":"2010","unstructured":"Kracker S.; Gardes P.; Mazerolles F.; Durandy A.; Immunoglobulin class switch recombination deficiencies. Clin Immunol  2010,135(2),193-203","journal-title":"Clin Immunol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev.immunol.26.021607.090248","volume":"26","author":"Stavnezer J.","year":"2008","unstructured":"Stavnezer J.; Guikema J.E.J.; Schrader C.E.; Mechanism and regulation of class switch recombination. Annu Rev Immunol  2008,26(1),261-292","journal-title":"Annu Rev Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/35080033","volume":"2","author":"Kinoshita K.","year":"2001","unstructured":"Kinoshita K.; Honjo T.; Linking class-switch recombination with somatic hypermutation. Nat Rev Mol Cell Biol  2001,2(7),493-503","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","volume":"102","author":"Muramatsu M.","year":"2000","unstructured":"Muramatsu M.; Kinoshita K.; Fagarasan S.; Yamada S.; Shinkai Y.; Honjo T.; Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell  2000,102(5),553-563","journal-title":"Cell"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/intimm\/dxu071","volume":"26","author":"Yousif A.S.","year":"2014","unstructured":"Yousif A.S.; Stanlie A.; Begum N.A.; Honjo T.; Opinion: Uracil DNA glycosylase (UNG) plays distinct and non-canonical roles in somatic hypermutation and class switch recombination. Int Immunol  2014,26(10),575-578","journal-title":"Int Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/bs.ai.2019.01.001","volume":"141","author":"Chen Z.","year":"2019","unstructured":"Chen Z.; Wang J.H.; Signaling control of antibody isotype switching. Adv Immunol  2019,141,105-164","journal-title":"Adv Immunol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1002\/eji.200324133","volume":"33","author":"Durandy A.","year":"2003","unstructured":"Durandy A.; Mini-review activation-induced cytidine deaminase: A dual role in class-switch recombination and somatic hypermutation. Eur J Immunol  2003,33(8),2069-2073","journal-title":"Eur J Immunol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.jaci.2012.03.043","volume":"129","author":"Uygungil B.","year":"2012","unstructured":"Uygungil B.; Bonilla F.; Lederman H.; Evaluation of a patient with hyper-IgM syndrome. J Allergy Clin Immunol  2012,129(6),1692-1693.e4","journal-title":"J Allergy Clin Immunol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0952-7915(00)00256-9","volume":"13","author":"Durandy A.","year":"2001","unstructured":"Durandy A.; Honjo T.; Human genetic defects in class-switch recombination (hyper-IgM syndromes). Curr Opin Immunol  2001,13(5),543-548","journal-title":"Curr Opin Immunol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1042\/bst0300815","volume":"30","author":"Durandy A.","year":"2002","unstructured":"Durandy A.; Hyper-IgM syndromes: A model for studying the regulation of class switch recombination and somatic hypermutation generation. Biochem Soc Trans  2002,30(4),815-818","journal-title":"Biochem Soc Trans"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2004.09.021","volume":"97","author":"Erd\u0151s M.","year":"2005","unstructured":"Erd\u0151s M.; Durandy A.; Mar\u00f3di L.; Genetically acquired class-switch recombination defects: The multi-faced hyper-IgM syndrome. Immunol Lett  2005,97(1),1-6","journal-title":"Immunol Lett"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jaci.2006.01.043","volume":"117","author":"Notarangelo L.D.","year":"2006","unstructured":"Notarangelo L.D.; Lanzi G.; Peron S.; Durandy A.; Defects of class-switch recombination. J Allergy Clin Immunol  2006,117(4),855-864","journal-title":"J Allergy Clin Immunol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/ar3904","volume":"14","author":"Durandy A.","year":"2012","unstructured":"Durandy A.; Kracker S.; Immunoglobulin class-switch recombination deficiencies. Arthritis Res Ther  2012,14(4),218","journal-title":"Arthritis Res Ther"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.3389\/fimmu.2018.02469","volume":"9","author":"Stebegg M.","year":"2018","unstructured":"Stebegg M.; Kumar S.D.; Silva-Cayetano A.; Fonseca V.R.; Linterman M.A.; Graca L.; Regulation of the germinal center response. Front Immunol  2018,9,2469","journal-title":"Front Immunol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12396","volume":"270","author":"Zhang Y.","year":"2016","unstructured":"Zhang Y.; Garcia-Ibanez L.; Toellner K.M.; Regulation of germinal center B-cell differentiation. Immunol Rev  2016,270(1),8-19","journal-title":"Immunol Rev"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/imr.12737","volume":"288","author":"Biram A.","year":"2019","unstructured":"Biram A.; Davidzohn N.; Shulman Z.; T cell interactions with B cells during germinal center formation, a three-step model. Immunol Rev  2019,288(1),37-48","journal-title":"Immunol Rev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","volume":"136","author":"Bonilla F.A.","year":"2015","unstructured":"Bonilla F.A.; Khan D.A.; Ballas Z.K.; Chinen J.; Frank M.M.; Hsu J.T.; Keller M.; Kobrynski L.J.; Komarow H.D.; Mazer B.; Nelson R.P.; Orange J.S.; Routes J.M.; Shearer W.T.; Sorensen R.U.; Verbsky J.W.; Bernstein D.I.; Blessing-Moore J.; Lang D.; Nicklas R.A.; Oppenheimer J.; Portnoy J.M.; Randolph C.R.; Schuller D.; Spector S.L.; Tilles S.; Wallace D.; Bonilla F.A.; Khan D.A.; Bernstein D.I.; Blessing-Moore J.; Khan D.; Lang D.; Nicklas R.A.; Oppenheimer J.; Portnoy J.M.; Randolph C.R.; Schuller D.; Spector S.L.; Tilles S.; Wallace D.; Bonilla F.A.; Ballas Z.K.; Chinen J.; Frank M.M.; Hsu J.T.; Keller M.; Kobrynski L.J.; Komarow H.D.; Mazer B.; Nelson R.P.; Orange J.S.; Routes J.M.; Shearer W.T.; Sorensen R.U.; Verbsky J.W.; Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol  2015,136(5),1186-1205.e78","journal-title":"J Allergy Clin Immunol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3389\/fimmu.2019.00945","volume":"10","author":"Kubagawa H.","year":"2019","unstructured":"Kubagawa H.; Honjo K.; Ohkura N.; Sakaguchi S.; Radbruch A.; Melchers F.; Jani P.K.; Functional roles of the IgM Fc receptor in the immune system. Front Immunol  2019,10,945","journal-title":"Front Immunol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fimmu.2019.00529","volume":"10","author":"Liu J.","year":"2019","unstructured":"Liu J.; Wang Y.; Xiong E.; Hong R.; Lu Q.; Ohno H.; Wang J.Y.; Role of the IgM Fc receptor in immunity and tolerance. Front Immunol  2019,10,529","journal-title":"Front Immunol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"484","DOI":"10.5505\/ejm.2023.35033","volume":"28","author":"Aycan N.","year":"2023","unstructured":"Aycan N.; Sazak S.; Samanc\u0131 N.; Evaluation of immunoglobulin levels in children aged 1-5 years with recurrent lower respiratory tract infections. East J Med  2023,28(3),484-491","journal-title":"East J Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s15010-010-0061-9","volume":"38","author":"Heinold A.","year":"2010","unstructured":"Heinold A.; Hanebeck B.; Daniel V.; Heyder J.; Tran T.H.; D\u00f6hler B.; Greil J.; M\u00fcller F.M.; Pitfalls of \u201chyper\u201d-IgM syndrome: A new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature. Infection  2010,38(6),491-496","journal-title":"Infection"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s10875-008-9171-x","volume":"28","author":"Jesus A.A.","year":"2008","unstructured":"Jesus A.A.; Duarte A.J.S.; Oliveira J.B.; Autoimmunity in hyper-IgM syndrome. J Clin Immunol  2008,28(S1),62-66","journal-title":"J Clin Immunol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1203\/01.PDR.0000139318.65842.4A","volume":"56","author":"Etzioni A.","year":"2004","unstructured":"Etzioni A.; Ochs H.D.; The hyper IgM syndrome - An evolving story. Pediatr Res  2004,56(4),519-525","journal-title":"Pediatr Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/pgmj.2009.080630","volume":"85","author":"Turvey S.E.","year":"2009","unstructured":"Turvey S.E.; Bonilla F.A.; Junker A.K.; Primary immunodeficiency diseases: A practical guide for clinicians. Postgrad Med J  2009,85(1010),660-666","journal-title":"Postgrad Med J"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1128\/CMR.00001-09","volume":"22","author":"Fried A.J.","year":"2009","unstructured":"Fried A.J.; Bonilla F.A.; Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev  2009,22(3),396-414","journal-title":"Clin Microbiol Rev"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10875-013-9954-6","volume":"34","author":"Costa-Carvalho B.T.","year":"2014","unstructured":"Costa-Carvalho B.T.; Grumach A.S.; Franco J.L.; Espinosa-Rosales F.J.; Leiva L.E.; King A.; Porras O.; Bezrodnik L.; Oleastro M.; Sorensen R.U.; Condino-Neto A.; Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice. J Clin Immunol  2014,34(1),10-22","journal-title":"J Clin Immunol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1756-0500-5-293","volume":"5","author":"Cab\u00e1n-Martinez A.J.","year":"2012","unstructured":"Cab\u00e1n-Martinez A.J.; Garc\u00eda-Beltr\u00e1n W.F.; Advancing medicine one research note at a time: The educational value in clinical case reports. BMC Res Notes  2012,5(1),293","journal-title":"BMC Res Notes"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jped.2020.12.002","volume":"97","author":"Sol\u00e9 D.","year":"2021","unstructured":"Sol\u00e9 D.; Primary immunodeficiencies: A diagnostic challenge? J Pediatr  2021,97,S1-S2","journal-title":"J Pediatr"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.3390\/jcm11144220","volume":"11","author":"Pieniawska-\u015amiech K.","year":"2022","unstructured":"Pieniawska-\u015amiech K.; Pasternak G.; Lewandowicz-Uszy\u0144ska A.; Jutel M.; Diagnostic challenges in patients with inborn errors of immunity with different manifestations of immune dysregulation. J Clin Med  2022,11(14),4220","journal-title":"J Clin Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/jamia\/ocaf092","volume":"33","author":"Noll R.","year":"2026","unstructured":"Noll R.; Berger A.; Facchinello C.; Stratmann K.; Schaaf J.; Storf H.; Enhancing diagnostic precision for rare diseases using case-based reasoning. J Am Med Inform Assoc  2026,33(1),98-111","journal-title":"J Am Med Inform Assoc"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1701384","DOI":"10.3389\/fimmu.2025.1701384","volume":"16","author":"Rivi\u00e8re J.G.","year":"2026","unstructured":"Rivi\u00e8re J.G.; Pasquet M.; Gambineri E.; Building alliances for early detection of immunodeficiencies: From primary care to hematology. Front Immunol  2026,16,1701384","journal-title":"Front Immunol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"318","DOI":"10.21911\/aai.2025.1070","volume":"23","author":"Yesilkaya S.","year":"2025","unstructured":"Yesilkaya S.; Vural Solak G.T.; Simsek Yurt N.; Yavuz E.; Knowledge and awareness of primary immunodeficiency in primary care: A survey of family physicians. Asthma Allergy Immunology  2025,23(3),318-327","journal-title":"Asthma Allergy Immunology"},{"key":"ref=58","unstructured":"warning signs of primary immunodeficiency.  Available from:  https:\/\/immunodeficiency.ca\/wp-content\/uploads\/2012\/08\/10-Warnings-en.pdf"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12887-018-1156-1","volume":"18","author":"Krauthammer A.","year":"2018","unstructured":"Krauthammer A.; Lahad A.; Goldberg L.; Sarouk I.; Weiss B.; Somech R.; Soudack M.; Pessach I.M.; Elevated IgM levels as a marker for a unique phenotype in patients with Ataxia telangiectasia. BMC Pediatr  2018,18(1),185","journal-title":"BMC Pediatr"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/039463201402700312","volume":"27","author":"Azarsiz E.","year":"2014","unstructured":"Azarsiz E.; Karaca N.E.; Gunaydin N.C.; Gulez N.; Ozturk C.; Aksu G.; Genel F.; Kutukculer N.; Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with ataxia-telangiectasia? Int J Immunopathol Pharmacol  2014,27(3),421-427","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/08820139.2020.1723104","volume":"50","author":"Amirifar P.","year":"2021","unstructured":"Amirifar P.; Mozdarani H.; Yazdani R.; Kiaei F.; Moeini Shad T.; Shahkarami S.; Abolhassani H.; Delavari S.; Sohani M.; Rezaei A.; Hassanpour G.; Akrami S.M.; Aghamohammadi A.; Effect of class switch recombination defect on the phenotype of ataxia-telangiectasia patients. Immunol Invest  2021,50(2-3),201-215","journal-title":"Immunol Invest"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"721289","DOI":"10.3389\/fimmu.2021.721289","volume":"12","author":"Perazzio S.F.","year":"2021","unstructured":"Perazzio S.F.; Palmeira P.; Moraes-Vasconcelos D.; Rangel-Santos A.; de Oliveira J.B.; Andrade L.E.C.; Carneiro-Sampaio M.; A critical review on the standardization and quality assessment of nonfunctional laboratory tests frequently used to identify inborn errors of immunity. Front Immunol  2021,12,721289","journal-title":"Front Immunol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"S272","DOI":"10.1016\/S2152-2650(20)30888-0","volume":"20","author":"Tomacinschii C.","year":"2020","unstructured":"Tomacinschii C.; Selevestru R.; Plaschevici I.; Golban R.; Tomacinschii V.; Sciuca S.; ABCL-311: The burden of non-hodgkin lymphoma developed in an ataxia telangiectasia child. Clin Lymphoma Myeloma Leuk  2020,20,S272-S273","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"972952","DOI":"10.3389\/fped.2022.972952","volume":"10","author":"Szczawi\u0144ska-Pop\u0142onyk A.","year":"2022","unstructured":"Szczawi\u0144ska-Pop\u0142onyk A.; T\u0105polska-J\u00f3\u017awiak K.; Schwartzmann E.; Pietrucha B.; Infections and immune dysregulation in ataxia-telangiectasia children with hyper-IgM and non-hyper-IgM phenotypes: A single-center experience. Front Pediatr  2022,10,972952","journal-title":"Front Pediatr"},{"key":"ref=65","first-page":"442","volume":"20","author":"Aghamohammadi A.","year":"2010","unstructured":"Aghamohammadi A.; Imai K.; Moazzami K.; Abolhassani H.; Tabatabaeiyan M.; Parvaneh N.; Nasiri Kalmarzi R.; Nakagawa N.; Oshima K.; Ohara O.; Nonoyama S.; Rezaei N.; Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome. J Investig Allergol Clin Immunol  2010,20(5),442-445","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/1744666X.2017.1292131","volume":"13","author":"Ghiasy S.","year":"2017","unstructured":"Ghiasy S.; Parvaneh L.; Azizi G.; Sadri G.; Zaki dizaji M.; Abolhassani H.; Aghamohammadi A.; The clinical significance of complete class switching defect in Ataxia telangiectasia patients. Expert Rev Clin Immunol  2017,13(5),499-505","journal-title":"Expert Rev Clin Immunol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.clim.2017.01.009","volume":"178","author":"van Os N.J.H.","year":"2017","unstructured":"van Os N.J.H.; Jansen A.F.M.; van Deuren M.; Haraldsson A.; van Driel N.T.M.; Etzioni A.; van der Flier M.; Haaxma C.A.; Morio T.; Rawat A.; Schoenaker M.H.D.; Soresina A.; Taylor A.M.R.; van de Warrenburg B.P.C.; Weemaes C.M.R.; Roeleveld N.; Willemsen M.A.A.P.; Ataxia-telangiectasia: Immunodeficiency and survival. Clin Immunol  2017,178,45-55","journal-title":"Clin Immunol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5633\/amm.2025.0109","volume":"64","author":"Jovanovi\u0107 N.","year":"2025","unstructured":"Jovanovi\u0107 N.; D\u017eopali\u0107 T.; What is Benta disease? Acta Medica Medianae  2025,64(1),64-70","journal-title":"Acta Medica Medianae"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"107005","DOI":"10.1016\/j.imlet.2025.107005","volume":"275","author":"Baldini L.","year":"2025","unstructured":"Baldini L.; Keller B.; Dewitte L.; Passarelli C.; Ginevrino M.; Carli D.; Montin D.; Bossuyt X.; Warnatz K.; Licciardi F.; BENTA disease or CARD11 gain-of-function? A novel variant with atypical features and a literature review. Immunol Lett  2025,275,107005","journal-title":"Immunol Lett"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10875-025-01872-4","volume":"45","author":"Nishinosono T.","year":"2025","unstructured":"Nishinosono T.; Muramatsu H.; Wakamatsu M.; Yamashita D.; Fukasawa T.; Shirakawa Y.; Sajiki D.; Maemura R.; Tsumura Y.; Yamamori A.; Narita K.; Kataoka S.; Narita A.; Nishio N.; Miyajima Y.; Takahashi Y.; Successful treatment with Sirolimus of a patient with a novel CARD11 germline mutation in B-cell expansion with nuclear factor Kappa B and T-Cell anergy: Case report and literature review. J Clin Immunol  2025,45(1),78","journal-title":"J Clin Immunol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"943027","DOI":"10.3389\/fimmu.2022.943027","volume":"13","author":"Zhao P.","year":"2022","unstructured":"Zhao P.; Hu Y.; Sun D.; Meng Q.; Zhang L.; Zhang X.; Tan L.; Zhang Y.; Ding Y.; He X.; A novel CARD11 germline mutation in a Chinese patient of B cell expansion with NF-\u03baB and T cell anergy (BENTA) and literature review. Front Immunol  2022,13,943027","journal-title":"Front Immunol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1626065","DOI":"10.3389\/fimmu.2025.1626065","volume":"16","author":"Garc\u00eda-Mart\u00ednez E.","year":"2025","unstructured":"Garc\u00eda-Mart\u00ednez E.; Schiaffino M.T.; Di Natale M.; D\u00edaz Luna M.M.; Viteri \u00c1lvarez D.A.; Mej\u00eda Gonz\u00e1lez M.A.; From syndromic clues to diagnosis: Understanding CARD11-driven disorders. Front Immunol  2025,16,1626065","journal-title":"Front Immunol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2007.03.002","volume":"37","author":"Moin M.","year":"2007","unstructured":"Moin M.; Aghamohammadi A.; Kouhi A.; Tavassoli S.; Rezaei N.; Ghaffari S.R.; Gharagozlou M.; Movahedi M.; Purpak Z.; MirSaeid Ghazi B.; Mahmoudi M.; Farhoudi A.; Ataxia-telangiectasia in Iran: Clinical and laboratory features of 104 patients. Pediatr Neurol  2007,37(1),21-28","journal-title":"Pediatr Neurol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jaci.2023.12.029","volume":"153","author":"Takada S.","year":"2024","unstructured":"Takada S.; Weitering T.J.; van Os N.J.H.; Du L.; Pico-Knijnenburg I.; Kuipers T.B.; Mei H.; Salzer E.; Willemsen M.A.A.P.; Weemaes C.M.R.; Pan-Hammarstrom Q.; van der Burg M.; Causative mechanisms and clinical impact of immunoglobulin deficiencies in ataxia telangiectasia. J Allergy Clin Immunol  2024,153(5),1392-1405","journal-title":"J Allergy Clin Immunol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12098-015-1852-x","volume":"83","author":"Rawat A.","year":"2016","unstructured":"Rawat A.; Imai K.; Suri D.; Gupta A.; Bhisikar S.; Saikia B.; Minz R.W.; Sehgal S.; Singh S.; Ataxia telangiectasia masquerading as hyper IgM syndrome. Indian J Pediatr  2016,83(3),270-271","journal-title":"Indian J Pediatr"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s10875-014-0106-4","volume":"35","author":"Brohl A.S.","year":"2015","unstructured":"Brohl A.S.; Stinson J.R.; Su H.C.; Badgett T.; Jennings C.D.; Sukumar G.; Sindiri S.; Wang W.; Kardava L.; Moir S.; Dalgard C.L.; Moscow J.A.; Khan J.; Snow A.L.; Germline CARD11 mutation in a patient with severe congenital B cell lymphocytosis. J Clin Immunol  2015,35(1),32-46","journal-title":"J Clin Immunol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3389\/fimmu.2018.01049","volume":"9","author":"Gupta M.","year":"2018","unstructured":"Gupta M.; Aluri J.; Desai M.; Lokeshwar M.; Taur P.; Lenardo M.; Bergerson J.; Dalvi A.; Mhatre S.; Kulkarni M.; Kambli P.; Madkaikar M.; Clinical, immunological, and molecular findings in four cases of B cell expansion with NF-\u03baB and T cell anergy disease for the first time from India. Front Immunol  2018,9,1049","journal-title":"Front Immunol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jaci.2015.03.008","volume":"136","author":"Buchbinder D.","year":"2015","unstructured":"Buchbinder D.; Stinson J.R.; Nugent D.J.; Heurtier L.; Suarez F.; Sukumar G.; Dalgard C.L.; Masson C.; Parisot M.; Zhang Y.; Matthews H.F.; Su H.C.; Durandy A.; Fischer A.; Kracker S.; Snow A.L.; Mild B-cell lymphocytosis in patients with a CARD11 C49Y mutation. J Allergy Clin Immunol  2015,136(3),819-821.e1","journal-title":"J Allergy Clin Immunol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1084\/jem.20120831","volume":"209","author":"Snow A.L.","year":"2012","unstructured":"Snow A.L.; Xiao W.; Stinson J.R.; Lu W.; Chaigne-Delalande B.; Zheng L.; Pittaluga S.; Matthews H.F.; Schmitz R.; Jhavar S.; Kuchen S.; Kardava L.; Wang W.; Lamborn I.T.; Jing H.; Raffeld M.; Moir S.; Fleisher T.A.; Staudt L.M.; Su H.C.; Lenardo M.J.; Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J Exp Med  2012,209(12),2247-2261","journal-title":"J Exp Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"S182","DOI":"10.1016\/j.jaci.2009.07.053","volume":"125","author":"Notarangelo L.D.","year":"2010","unstructured":"Notarangelo L.D.; Primary immunodeficiencies. J Allergy Clin Immunol  2010,125(2),S182-S194","journal-title":"J Allergy Clin Immunol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1080\/1744666X.2024.2372335","volume":"20","author":"Yazdanpanah N.","year":"2024","unstructured":"Yazdanpanah N.; Rezaei N.; The multidisciplinary approach to diagnosing inborn errors of immunity: A comprehensive review of discipline-based manifestations. Expert Rev Clin Immunol  2024,20(10),1237-1259","journal-title":"Expert Rev Clin Immunol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"780140","DOI":"10.3389\/fimmu.2021.780140","volume":"12","author":"Nordin J.","year":"2021","unstructured":"Nordin J.; Sol\u00eds L.; Pr\u00e9vot J.; Mahlaoui N.; Chapel H.; S\u00e1nchez-Ram\u00f3n S.; Ali A.; Seymour J.W.; Pergent M.; The PID principles of care: Where are we now? A global status report based on the PID life index. Front Immunol  2021,12,780140","journal-title":"Front Immunol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12026-011-8241-y","volume":"51","author":"Modell V.","year":"2011","unstructured":"Modell V.; Gee B.; Lewis D.B.; Orange J.S.; Roifman C.M.; Routes J.M.; Sorensen R.U.; Notarangelo L.D.; Modell F.; Global study of primary immunodeficiency diseases (PI)\u2014 Diagnosis, treatment, and economic impact: An updated report from the Jeffrey Modell Foundation. Immunol Res  2011,51(1),61-70","journal-title":"Immunol Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2249.2009.03954.x","volume":"157","author":"Gathmann B.","year":"2009","unstructured":"Gathmann B.; Grimbacher B.; Beaut\u00e9 J.; Dudoit Y.; Mahlaoui N.; Fischer A.; Knerr V.; Kindle G.; The European internet-based patient and research database for primary immunodeficiencies: Results 2006\u20132008. Clin Exp Immunol  2009,157(Suppl 1),3-11","journal-title":"Clin Exp Immunol"},{"key":"ref=85","first-page":"101","volume":"3","author":"Notarangelo L.D.","year":"1992","unstructured":"Notarangelo L.D.; Duse M.; Ugazio A.G.; Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev  1992,3(2),101-121","journal-title":"Immunodefic Rev"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12016-013-8378-7","volume":"46","author":"Qamar N.","year":"2014","unstructured":"Qamar N.; Fuleihan R.L.; The hyper IgM syndromes. Clin Rev Allergy Immunol  2014,46(2),120-130","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/256708","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/256708\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/256708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T06:02:56Z","timestamp":1794808976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/256708\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":86,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715303480200260716045547","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2026-02-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e18715303480200"}}